Does the use of recombinant TSH in preparation for I-131 scintigraphy scan affect hearing function?
- PMID: 29937862
- PMCID: PMC6002631
- DOI: 10.1016/j.joto.2017.10.001
Does the use of recombinant TSH in preparation for I-131 scintigraphy scan affect hearing function?
Abstract
Objective: The objective of this study was to examine the effect of hypothyroidism on hearing function in patients surgically treated for differentiated thyroid cancer and subsequently experienced hypothyroidism during preparation for follow up I-131 scintigraphy scan by either recombinant human thyroid stimulating hormone (rhTSH) treatment or thyroid hormone withdrawal (THW).
Methods: A total of 55 patients undergoing I-131 scintigraphy scan following surgeries for differentiated thyroid cancer were included in the study, including 25 patients prepared by administration of recombinant TSH (rhTSH Group) and 30 patients by thyroid hormone withdrawal (THW Group).
Results: Air conduction thresholds at 1, 2 and 4 kHz for both ears were higher during hypothyroid period than during euthyroid period for patients in the THW group (p < 0.05) but not for patients in the rhTSH group.
Conclusion: Sensorineural hearing loss was detected, especially at low frequencies, in patients with DTC after surgical treatment whose hormone replacement therapy was withdrawn but not in those receiving rhTSH. It is therefore preferred to use rhTSH when preparing for I-131 scintigraphy scan in patients at risk for hearing loss.
Keywords: Hearing loss; Radioiodine; Recombinant TSH; Thyroid hormone withdrawal.
Similar articles
-
Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in 124I PET/CT-Based Dosimetry for 131I Therapy of Metastatic Differentiated Thyroid Cancer.J Nucl Med. 2017 Jul;58(7):1146-1154. doi: 10.2967/jnumed.116.179366. Epub 2017 Jan 19. J Nucl Med. 2017. PMID: 28104741 Free PMC article.
-
Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal preparation for radioiodine ablation in differentiated thyroid cancer in children, adolescents and young adults.Clin Endocrinol (Oxf). 2021 Aug;95(2):344-353. doi: 10.1111/cen.14457. Epub 2021 Mar 29. Clin Endocrinol (Oxf). 2021. PMID: 33704813
-
Sensitivity of preparation with rhTSH or thyroid hormone withdrawal using ¹³¹I-whole body scans to identify metastases of differentiated thyroid cancer.Int J Surg. 2015 Apr;16(Pt A):107-112. doi: 10.1016/j.ijsu.2015.02.016. Epub 2015 Mar 11. Int J Surg. 2015. PMID: 25771100
-
Potential use of recombinant human thyrotropin in the treatment of distant metastases in patients with differentiated thyroid cancer.Endocr Pract. 2013 Jan-Feb;19(1):139-48. doi: 10.4158/EP12244.RA. Endocr Pract. 2013. PMID: 23186979 Free PMC article. Review.
-
rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.Endocr Relat Cancer. 2005 Mar;12(1):49-64. doi: 10.1677/erc.1.00830. Endocr Relat Cancer. 2005. PMID: 15788638 Review.
References
-
- American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper D.S., Doherty G.M., Haugen B.R., Kloos R.T., Lee S.L., Mandel S.J., Mazzaferri E.L., McIver B., Pacini F., Schlumberger M., Sherman S.I., Steward D.L., Tuttle R.M. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–1214. - PubMed
-
- Bhatia P.L., Gupta O.P., Agrawal M.K. Audiological and vestibular function test in hypothyroidism. Laryngoscope. 1977;87:2082–2089. - PubMed
-
- Bircher H. Der endemische Kropf und seine Beziehun- gen zur Taubstummheit und zum Kretinismus (Endemic Goitre in Relation to Deaf-mut Kemp WR (1907) Deafness in myxoedema. Br. Med. J. 1883;(1):375.
-
- Buck A.K., Nekolla S., Ziegler S., Beer A., Krause B.J., Herrmann K. SPECT/CT. JNM. 2008;49:1305–1319. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources